|
ISIN No
|
INE376G01013
|
BSE Code / NSE Code
|
532523 / BIOCON
|
Book Value (Rs.)
|
209.69
|
Face Value
|
5.00
|
|
Bookclosure
|
03/07/2026
|
52Week High
|
447
|
EPS
|
2.37
|
P/E
|
173.75
|
|
Market Cap.
|
66996.73 Cr.
|
52Week Low
|
337
|
P/BV / Div Yield (%)
|
1.96 / 0.12
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view the investment break up of the company with details such as Security name, Security type, Company type, investmement cost etc.
| YearEnd | Security Name | Security Type | Company Type | Cost of Investments |
| 2603 |
Biocon Biologics Ltd.
| Equity Share | Subsidiary | 16411.00 |
| 2603 |
Biocon Biologics Ltd.
| Debenture | Subsidiary | 4288.20 |
| 2603 |
Syngene International Ltd.
| Equity Share | Subsidiary | 2008.90 |
| 2603 |
Biocon Pharma Ltd.
| Preference Share | Subsidiary | 1086.20 |
| 2603 |
Biocon Biosphere Ltd.
| Preference Share | Subsidiary | 746.60 |
| 2603 |
Biocon Biologics Ltd.
| Preference Share | Subsidiary | 205.40 |
| 2603 |
Investment in mutual funds
| Mutual Fund Scheme | Mutual Fund | 172.10 |
| 2603 |
Bicara Therapeutics Inc.
| Equity Share | Subsidiary | 21.60 |
|